Log In
Print this Print this

Gleevec, Glivec, imatinib mesylate (QTI571)

Also known as: Ruvise (CGP 57148B) (formerly STI-571)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionBCR-ABL tyrosine kinase inhibitor
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL)
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today